Logo image of CVRX

CVRX INC (CVRX) Stock Fundamental Analysis

NASDAQ:CVRX - Nasdaq - US1266381052 - Common Stock - Currency: USD

6.16  -0.03 (-0.48%)

Fundamental Rating

3

Taking everything into account, CVRX scores 3 out of 10 in our fundamental rating. CVRX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. CVRX may be in some trouble as it scores bad on both profitability and health. CVRX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CVRX had negative earnings in the past year.
In the past year CVRX has reported a negative cash flow from operations.
In the past 5 years CVRX always reported negative net income.
CVRX had a negative operating cash flow in each of the past 5 years.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

CVRX's Return On Assets of -44.95% is on the low side compared to the rest of the industry. CVRX is outperformed by 64.55% of its industry peers.
With a Return On Equity value of -84.39%, CVRX perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
Industry RankSector Rank
ROA -44.95%
ROE -84.39%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

CVRX has a better Gross Margin (83.75%) than 94.71% of its industry peers.
CVRX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVRX has been increased compared to 1 year ago.
CVRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CVRX is higher compared to a year ago.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -4.10, we must say that CVRX is in the distress zone and has some risk of bankruptcy.
CVRX has a Altman-Z score of -4.10. This is in the lower half of the industry: CVRX underperforms 65.61% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that CVRX is somewhat dependend on debt financing.
The Debt to Equity ratio of CVRX (0.69) is worse than 67.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z -4.1
ROIC/WACCN/A
WACC8.73%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 12.06 indicates that CVRX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 12.06, CVRX belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
A Quick Ratio of 10.94 indicates that CVRX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 10.94, CVRX belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.06
Quick Ratio 10.94
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.74% over the past year.
The Revenue has grown by 30.53% in the past year. This is a very strong growth!
The Revenue has been growing by 52.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)11.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.04%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%14.65%

3.2 Future

Based on estimates for the next years, CVRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.24% on average per year.
CVRX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.25% yearly.
EPS Next Y22.22%
EPS Next 2Y14.8%
EPS Next 3Y12.59%
EPS Next 5Y10.24%
Revenue Next Year12.54%
Revenue Next 2Y16.16%
Revenue Next 3Y13.99%
Revenue Next 5Y21.25%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CVRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CVRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

CVRX's earnings are expected to grow with 12.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.8%
EPS Next 3Y12.59%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CVRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CVRX INC

NASDAQ:CVRX (5/16/2025, 10:02:00 AM)

6.16

-0.03 (-0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners67.49%
Inst Owner Change2.3%
Ins Owners4.21%
Ins Owner Change8.61%
Market Cap160.53M
Analysts81.54
Price Target17.54 (184.74%)
Short Float %5.27%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.69%
Min EPS beat(2)-19.26%
Max EPS beat(2)-12.12%
EPS beat(4)0
Avg EPS beat(4)-34.15%
Min EPS beat(4)-88.53%
Max EPS beat(4)-12.12%
EPS beat(8)4
Avg EPS beat(8)-9.78%
EPS beat(12)8
Avg EPS beat(12)-4.18%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)-0.14%
Revenue beat(4)0
Avg Revenue beat(4)-2.53%
Min Revenue beat(4)-7.43%
Max Revenue beat(4)-0.14%
Revenue beat(8)3
Avg Revenue beat(8)1.44%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.31%
PT rev (3m)-9.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.43%
EPS NY rev (1m)-2.65%
EPS NY rev (3m)-7.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.13
P/FCF N/A
P/OCF N/A
P/B 2.26
P/tB 2.26
EV/EBITDA N/A
EPS(TTM)-2.18
EYN/A
EPS(NY)-1.83
Fwd EYN/A
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.5
OCFYN/A
SpS1.97
BVpS2.73
TBVpS2.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.95%
ROE -84.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.75%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score2
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 219.87%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.06
Quick Ratio 10.94
Altman-Z -4.1
F-Score2
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)167.13%
Cap/Depr(5y)316.6%
Cap/Sales(3y)2.41%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.04%
EPS Next Y22.22%
EPS Next 2Y14.8%
EPS Next 3Y12.59%
EPS Next 5Y10.24%
Revenue 1Y (TTM)30.53%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%14.65%
Revenue Next Year12.54%
Revenue Next 2Y16.16%
Revenue Next 3Y13.99%
Revenue Next 5Y21.25%
EBIT growth 1Y-38.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.5%
EBIT Next 3Y13.41%
EBIT Next 5YN/A
FCF growth 1Y-2.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.32%
OCF growth 3YN/A
OCF growth 5YN/A